Literature DB >> 24333309

Plasma-derived medicinal products: demand and clinical use.

Giuliano Grazzini1, Pier Mannuccio Mannucci2, Fabrizio Oleari3.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333309      PMCID： PMC3853983          DOI： 10.2450/2013.002s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  22 in total

Review 1.  Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy.

Authors:  Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

Review 2.  Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.

Authors:  Gabriele Calizzani; Samantha Profili; Fabio Candura; Monica Lanzoni; Stefania Vaglio; Livia Cannata; Liviana Catalano; Rosa Chianese; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 3.  Public expenditure for plasma-derived and recombinant medicinal products in Italy.

Authors:  Monica Lanzoni; Fabio Candura; Gabriele Calizzani; Claudia Biffoli; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 4.  Plasma-derived medicinal products in Italy: information sources and flows.

Authors:  Monica Lanzoni; Claudia Biffoli; Fabio Candura; Gabriele Calizzani; Stefania Vaglio; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 5.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 6.  Clinical use and the Italian demand for activated prothrombin complex and activated recombinant factor VII concentrates.

Authors:  Antonio Coppola; Annarita Tagliaferri; Gabriele Calizzani; Fabio Candura; Massimo Franchini; Carlo Ruosi; Giuliano Grazzini; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

Review 7.  Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?

Authors:  Vincenzo De Angelis; Antonio Breda
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

8.  Europe recommends ban on common plasma substitute.

Authors:  Jacqui Wise
Journal:  BMJ       Date:  2013-06-17

Review 9.  Purchasing factor concentrates in the 21st century through competitive tendering.

Authors:  C R M Hay
Journal:  Haemophilia       Date:  2013-05-28       Impact factor: 4.287

10.  Models for institutional and professional accreditation of haemophilia centres in Italy.

Authors:  G Calizzani; S Vaglio; R Arcieri; I Menichini; A Tagliaferri; S Antoncecchi; M T Carloni; A Breda; E Santagostino; A Ghirardini; M R Tamburrini; M Morfini; P M Mannucci; G Grazzini
Journal:  Haemophilia       Date:  2013-04-05       Impact factor: 4.287
View more
  1 in total

Review 1.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.